4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-25-000624
Chief Financial Officer acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Emany Sravan Kumar Chief Financial Officer | 2024-12-31 | Grant or award | +80,000 | 80,000 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Emany Sravan Kumar Chief Financial Officer | 2024-12-31 | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…